NACFC | Plenary 1: Hope for All: Addressing the Needs of Those With Untreated CF Mutations

(1:19:25)

CF Foundation | Reproductive Health in Cystic Fibrosis

(1:21:29)

CF Foundation | Challenges \u0026 Progress in the Pursuit of Genetic Therapies for Cystic Fibrosis

(1:24:35)

NACFC 2021 | Plenary 2: Working Together to Pave the Path to a Cure

(59:32)

NACFC | Plenary 2: Novel CF Therapeutics \u0026 Clinical Trial Strategy to Accelerate Our Mission

(1:13:17)

NACFC 2021 | Plenary 3: Expanding the Horizon of Therapies for the Underlying Cause of CF

(59:58)

NACFC 2021 | Plenary 1: Meeting the Moment: Lessons for a Changing World

(1:11:13)

CF Foundation | 2017 NACFC Plenary 1: Matching Medicines With Mutations

(1:46:56)

CF Foundation | The Tipping Point: The Journey to Understand \u0026 Advance Research in CFRD

(1:22:32)

NACFC 2020 | Plenary 1: Laying the Foundation for the Path to a Cure

(57:53)

NACFC | Plenary 3: Evolving With the Times: Staying Agile With a Diverse \u0026 Aging CF Population

(1:4:43)

NACFC 2024 | S08: The Impact of HEMT on the Vicious Cycle of Obstruction, Infection, \u0026 Inflammation

(2:37)

CF Foundation | NACFC 2016: Plenary 3

(1:5:25)

CF Foundation | NACFC 2016: Plenary 1

(1:37:32)

CF Foundation | NACFC 2016: Plenary 2

(1:8:45)

NACFC 2018 | Plenary 2: Anti-Inflammatories and Mucociliary Clearance Therapies

(55:30)

NACFC 2018 | Plenary 3: Partnering: The Oldest New Idea to Improve CF Care

(1:5:38)

NACFC 2018 | Plenary 1: Improving Outcomes of Infections in the Age of CFTR Modulators

(1:18:8)

NACFC 2020 | Plenary 3: Advancing the GI Frontier for People With CF

(51:4)

NACFC 2015 | Plenary 2

(1:1:42)